Experts in breast cancer review clinical cases, discuss individualized treatment options and key clinical trials.
EP. 1: Case 1: 63-Year-Old Woman With Relapsed HER2+ Breast Cancer
The experts discuss a case presentation of a 63-year-old woman with relapsed HER2+ metastatic breast cancer and discuss rate of relapse in this patient population.
EP. 2: Case 1: DESTINY-Breast01
Experts discuss the treatment considerations for HER2+ metastatic breast cancer and provide an overview of the DESTINY-Breast01 trial.
EP. 3: Case 1: HER2CLIMB Trial
The experts have a detailed conversation on the HER2CLIMB trial, including third-line treatment options and the importance of having a detailed and balanced conversation with patients.
EP. 4: Case 1: Practical Experience With the HER2CLIMB Regimen
The panelists discuss clinical experience with the HER2CLIMB regimen, including main adverse effects.
EP. 5: Case 2: Relapsed HER2+ Metastatic Breast Cancer With Stable Brain Mets
The experts present and discuss a case of a patient with relapsed HER2+ metastatic breast cancer with stable brain metastases.
EP. 6: Case 2: Looking at Data in Breast Cancer Patients With Brain Mets
The experts discuss data from clinical trials of metastatic breast cancer with brain involvement.
EP. 7: Case 2: Later-Lines of Treatment in Metastatic Breast Cancer
Key opinion leaders consider later-lines of therapy in metastatic breast cancer with lung and brain involvement.
EP. 8: Case 2: Clinical Experience with the Tucatinib Regimen
A panel of experts review the tucatinib regimen including adverse effects to keep an eye on.
EP. 9: Case 3: Relapsed HER2+ Metastatic Breast Cancer With Progressing Brain Mets
Presentation and considerations for relapsed HER2+ metastatic breast cancer with progressing brain metastases.
EP. 10: Case 3: The NALA Trial
Experts have a detailed conversation on the NALA trial of neratinib and capecitabine for HER2+ metastatic breast cancer.
EP. 11: Case 3: The SOPHIA Trial
The experts describe the SOPHIA study of margetuximab in HER2+ advanced breast cancer.
2 Clarke Drive Cranbury, NJ 08512